Consolidated Statement Of Cash Flows

JCR Pharmaceuticals Co.,Ltd. - Filing #7604217

Concept 2021-04-01 to
2022-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2020-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
19,404,000,000 JPY
19,317,000,000 JPY
8,653,000,000 JPY
8,825,000,000 JPY
Depreciation
1,945,000,000 JPY
1,892,000,000 JPY
Interest and dividend income
-35,000,000 JPY
-33,000,000 JPY
Interest expenses
45,000,000 JPY
42,000,000 JPY
Increase (decrease) in provision for bonuses
51,000,000 JPY
137,000,000 JPY
Increase (decrease) in retirement benefit liability
74,000,000 JPY
74,000,000 JPY
Foreign exchange losses (gains)
-544,000,000 JPY
-140,000,000 JPY
Subtotal
11,817,000,000 JPY
11,156,000,000 JPY
Decrease (increase) in trade receivables
-7,402,000,000 JPY
-205,000,000 JPY
Decrease (increase) in inventories
-1,082,000,000 JPY
-4,699,000,000 JPY
Net cash provided by (used in) operating activities
9,289,000,000 JPY
10,341,000,000 JPY
Increase (decrease) in trade payables
-1,608,000,000 JPY
2,253,000,000 JPY
Other, net
-143,000,000 JPY
265,000,000 JPY
Interest and dividends received
35,000,000 JPY
39,000,000 JPY
Interest paid
-45,000,000 JPY
-46,000,000 JPY
Cash flows from investing activities
Payments into time deposits
-300,000,000 JPY
-300,000,000 JPY
Proceeds from withdrawal of time deposits
300,000,000 JPY
345,000,000 JPY
Purchase of property, plant and equipment
-11,333,000,000 JPY
-4,780,000,000 JPY
Purchase of investment securities
JPY
-91,000,000 JPY
Net cash provided by (used in) investing activities
-3,250,000,000 JPY
-3,290,000,000 JPY
Other, net
-84,000,000 JPY
152,000,000 JPY
Cash flows from financing activities
Dividends paid
-2,169,000,000 JPY
-1,083,000,000 JPY
Proceeds from issuance of bonds
JPY
500,000,000 JPY
Proceeds from long-term borrowings
750,000,000 JPY
1,250,000,000 JPY
Repayments of long-term borrowings
-750,000,000 JPY
-650,000,000 JPY
Net cash provided by (used in) financing activities
-2,179,000,000 JPY
8,304,000,000 JPY
Repayments of lease liabilities
-20,000,000 JPY
-47,000,000 JPY
Other, net
JPY
1,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
612,000,000 JPY
-22,000,000 JPY
Net increase (decrease) in cash and cash equivalents
4,472,000,000 JPY
15,332,000,000 JPY
Cash and cash equivalents
30,733,000,000 JPY
26,260,000,000 JPY
10,928,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.